life science

life science

Venture Investing in Life Science Start-ups: Dennis Purcell, Aisling Capital

17h ago
SOURCE  

Description

As part of the CTV Tech Commercialization Series, Dennis Purcell, Senior Managing Director at Aisling Capital shares his thoughts on trends in biopharma venture investing [0:12]; East Coast investment strategies [8:51]; NYC as a capital for startups [14:36]; tips for biotech entrepreneurs [23:54]; careers in venture capital [37:08]; and answers questions from the audience [45:00]. Columbia Technology Ventures is the technology transfer office at Columbia University. For more information on us, please visit techventures.columbia.edu. About the speakers: Dennis Purcell has served as the Senior Managing Director of Aisling Capital since February 2000 and is responsible for the management of the Partnership. The fund has approximately $1.7 billion of assets under management. Prior to joining Aisling Capital, Mr. Purcell served as Managing Director of the Life Sciences Investment Banking Group at Chase H&Q for over five years where he supervised over $10 billion of financing and advisory assignments in the pharmaceutical, biotechnology, and medical products industries. Mr. Purcell is a frequent commentator on the industry and has been honored in the "Biotech Hall of Fame" by Genetic Engineering News, named to the Biotechnology All-Stars list by Forbes ASAP and honored as one of the top 50 Irish- American businessmen and cited as the top 100 contributors to the biotechnology industry. Prior to joining H&Q, Mr. Purcell was a Managing Director in the Healthcare Group at PaineWebber, Inc. Mr. Purcell currently serves as a director of Paratek Pharmaceuticals, Inc. Previously he served as a director of Aton Pharmaceuticals, Inc., Bridge Pharmaceuticals, Inc., Cengent Therapeutics, Inc., Dynova Laboratories, Inc., Valentis, Inc. and Xanodyne Pharmaceuticals, Inc. He has served as a member of the Advisory Council at Harvard Medical School, the Board of Directors of the Biotechnology Industry Association, as well as the New York Biotechnology Association and the Irvington Institute. He also serves on the Board of L.E.K. consulting. Mr. Purcell received his M.B.A. from Harvard University and his B.S. in Accounting from the University of Delaware. Orin Herskowitz Orin Herskowitz is the VP of Intellectual Property and Tech Transfer for Columbia University, as well as Executive Director of Columbia Technology Ventures (CTV). He also is an Adjunct Professor at Columbia Business School`. He is a Board Member of a number of innovation and entrepreneurship-focused initiatives in NYC, including the NYC Media Lab, PowerBridgeNY, and HarlemBiospace. Orin received his BA from Yale and his MBA from the Wharton School of Business. Prior to joining Columbia, Orin spent 7 years at the Boston Consulting Group's New York office as a strategy consultant, and was previously an entrepreneur and a consultant to start-ups.